Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02755467 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Treatment of Spider Angioma
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02755467: Completed NA study, sponsored by Cutera.
NCT02755467 is a NA study that has completed, run by Cutera. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02755467, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.
Primary Outcome
Assessment of Baseline vs. 4 weeks post-final treatment for improvement of spider angiomas using the Physician's Global Assessment scale. High scores indicate better outcomes: 0\. None 1. Mild 2. Moderate 3. Significant 4. Very Significant 5. Complete Removal
Interventions
- DEVICE KTP laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-05-26 |
| Est. Completion | 2017-04-04 |
| Phase | NA |
What the finished NCT02755467 record still lists
NCT02755467 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which KTP laser is the first listed.
NCT02755467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02755467 about?
NCT02755467 is a clinical study titled "Clinical Evaluation of the Treatment of Spider Angioma". To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.
What is the current status of trial NCT02755467?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-05-26. Estimated completion is 2017-04-04.
What interventions are being tested in trial NCT02755467?
The interventions under investigation include: KTP laser (DEVICE).
Who is sponsoring clinical trial NCT02755467?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02755467's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI